Gd Safety & Deposition: Impact on Practice, European Perspective
Harriet Thöny
The detection of NSF in patients with impaired renal function and the deposition of GBCA in the brain of patients with normal renal function has led to a dramatic change in the administration of these agents in Europe.
This abstract and the presentation materials are available to members only;
a login is required.
